US Food and Drug Administration

被引：0
|
作者：
Blumenthal, G. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
regulation; development; access;
D O I：
10.1016/j.jtho.2019.08.111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES10.01
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [1] US food and drug administration
    Goodman, Jesse
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
  • [2] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
  • [3] Urokinase and the US food and drug administration
    Ouriel, K
    JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
  • [4] Independence at the US Food and Drug Administration
    不详
    LANCET, 2006, 367 (9523): : 1630 - 1630
  • [5] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [6] Integrated Drug Reviews at the US Food and Drug Administration
    Woodcock, Janet
    Stein, Peter
    Bugin, Kevin
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1248 - 1250
  • [7] Surgical Innovation and the US Food and Drug Administration
    Cundiff, Geoffrey W.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
  • [8] US Food and Drug Administration pushed to change
    McCarthy, M
    LANCET, 2006, 367 (9523): : 1643 - 1644
  • [9] Increasing Transparency at the US Food and Drug Administration
    Steinbrook, Robert
    JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1146 - 1147
  • [10] US Food and Drug Administration gets it right
    Grove, ML
    BRITISH MEDICAL JOURNAL, 2002, 325 (7367): : 776 - 776
12345